Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions.
about
Heavy use versus less heavy use of sedatives among non-medical sedative users: Characteristics and correlatesPropylene glycol toxicity in children.Sedation, analgesia, and delirium in the critically ill patient.Sedation and analgesia in the mechanically ventilated patient.Sedation for critically ill or injured adults in the intensive care unit: a shifting paradigm.Emergency neurological life support: airway, ventilation, and sedation.Emergency Neurological Life Support: Airway, Ventilation, and Sedation.Development and Evaluation of a Guideline for Monitoring Propylene Glycol Toxicity in Pediatric Intensive Care Unit Patients Receiving Continuous Infusion Lorazepam.Serum osmolal gap in clinical practice: usefulness and limitations.Considerations for analgosedation and antithrombotic management during extracorporeal life support.A Review of Agents for Palliative Sedation/Continuous Deep Sedation: Pharmacology and Practical Applications.A Symptom-Triggered Benzodiazepine Protocol Utilizing SAS and CIWA-Ar Scoring for the Treatment of Alcohol Withdrawal Syndrome in the Critically Ill.Effect of Extracorporeal Membrane Oxygenation Use on Sedative Requirements in Patients with Severe Acute Respiratory Distress Syndrome.Emergency Neurological Life Support: Airway, Ventilation, and Sedation.Drug-induced hyperlactatemia.
P2860
Q34311279-595DBAF4-2E81-4ADA-ABED-B054A17B1B61Q35124117-B654D769-AA93-4DEF-B987-D80A7677808DQ37867312-E744463C-7050-48B2-A9EC-FB8B760950BAQ37948029-9285286F-E035-4581-8079-D1C7A8524BEEQ38040844-91AF1885-E09C-4D71-9407-DE7B3EDE8ABCQ38042830-F4673A25-C355-4A9D-A070-389EDB60E625Q38599740-535DF4AC-483F-4FD5-864A-D47EE26463BCQ38608791-B25548A7-061C-4F99-B397-B1ED60410356Q38901212-7E82CF71-4E27-48F0-9D6F-C3225C60E258Q39169651-5E969935-3D52-4060-9BA1-DD041B7941DEQ39175922-CA08450D-8E5C-47E5-89D7-43FB89018D30Q39297857-92026434-985C-46E1-86B2-E04184A3284FQ39808379-CAB02CB7-F889-460A-9D2F-B6F369113A1BQ48111715-2C7D14BB-AB71-40AA-8219-59CE99FB6949Q53797180-BF2033C7-DE8A-4D6D-88C4-508AAED45420
P2860
Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Propylene glycol accumulation ...... travenous lorazepam infusions.
@en
Propylene glycol accumulation ...... travenous lorazepam infusions.
@nl
type
label
Propylene glycol accumulation ...... travenous lorazepam infusions.
@en
Propylene glycol accumulation ...... travenous lorazepam infusions.
@nl
prefLabel
Propylene glycol accumulation ...... travenous lorazepam infusions.
@en
Propylene glycol accumulation ...... travenous lorazepam infusions.
@nl
P2093
P2860
P356
P1476
Propylene glycol accumulation ...... travenous lorazepam infusions.
@en
P2093
Douglas N Fish
Erica L Horinek
Robert MacLaren
P2860
P304
P356
10.1345/APH.1M313
P407
P577
2009-11-17T00:00:00Z